Demand for vascular ulcer treatment will increase through 2036, with arterial ulcers at 28.0% of the ulcer type segment in 2026, driven by standardized treatment protocols and established clinical procurement patterns. The market is projected to reach USD 3.3 billion in 2026 and USD 5.22 billion by 2036.